Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review

Document Sample
Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					        Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDPH129011FSA                                                                                                                        Publication Date: DEC 2013




       Table of Contents
       Table of Contents ............................................................................................................................................................................... 1
          List of Tables .................................................................................................................................................................................. 2
          List of Figures ................................................................................................................................................................................. 2
       Section 1 - About the Company.......................................................................................................................................................... 4
       Solagran Limited - Key Facts ............................................................................................................................................................. 4
       Solagran Limited - Key Employees .................................................................................................................................................... 5
       Solagran Limited - Major Products and Services................................................................................................................................ 6
       Solagran Limited - History .................................................................................................................................................................. 7
       Solagran Limited - Company Statement ............................................................................................................................................. 8
       Solagran Limited - Locations And Subsidiaries ................................................................................................................................ 12
          Head Office ................................................................................................................................................................................... 12
       Section 2 – Company Analysis ......................................................................................................................................................... 13
       Solagran Limited - Business Description .......................................................................................................................................... 13
       Solagran Limited - SWOT Analysis .................................................................................................................................................. 14
          SWOT Analysis - Overview........................................................................................................................................................... 14
          Solagran Limited - Strengths ........................................................................................................................................................ 14
             Strength - Focused Research and Development Activities ....................................................................................................... 14
             Strength - Strong Cash Flows ................................................................................................................................................... 14
          Solagran Limited - Weaknesses ................................................................................................................................................... 14
             Weakness - Pending Litigations ................................................................................................................................................ 14
             Weakness - Weak Financial Performance ................................................................................................................................ 14
          Solagran Limited - Opportunities .................................................................................................................................................. 15
             Opportunity - Strategic Partnerships/Collaborations.................................................................................................................. 15
             Opportunity - Changing Demographics ..................................................................................................................................... 15
             Opportunity - Biotech Focus ...................................................................................................................................................... 15
          Solagran Limited - Threats............................................................................................................................................................ 16
             Threat - Uncertain R&D Outcomes ........................................................................................................................................... 16
             Threat - Rapid Technological Change ....................................................................................................................................... 16
             Threat - Industry Consolidation ................................................................................................................................................. 16
       Solagran Limited - Key Competitors ................................................................................................................................................. 17
       Section 3 – Company Financial Ratios ............................................................................................................................................. 18
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 18
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 18
       Performance Chart ........................................................................................................................................................................... 20
       Financial Ratios - Interim Ratios....................................................................................................................................................... 21
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 22
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 23
          Solagran Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................. 23
          Solagran Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ...................................
				
DOCUMENT INFO
Description: Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Solagran Limited (Solagran) is a pharmaceutical company. The company researches, develops and commer
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.